You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 121476


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 121476

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 3, 2039 Incyte Corp PEMAZYRE pemigatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR121476: Scope, Claims, and Patent Landscape

Last updated: August 7, 2025


Introduction

Patent AR121476 pertains to a pharmaceutical invention filed under Argentine patent law, embodying technological innovation within the medicinal domain. Understanding the scope and claims of this patent provides critical insights into its legal strength, competitive positioning, and potential for commercialization within Argentina and beyond. This analysis assesses the patent's claims, the breadth of its protection, and its position within the existing patent landscape, equipping stakeholders—pharmaceutical companies, attorneys, and licensing entities—with actionable intelligence.


Patent Overview and Context

Patent AR121476 was granted by the Argentine National Institute of Industrial Property (INPI), addressing a specific drug or therapeutic compound. The patent's filing date, priority, and expiration timeline are crucial for strategic planning:

  • Filing and Grant Dates: While precise dates are not specified here, Argentine patents generally offer 20 years from the earliest filing date, subject to maintenance (renewals).
  • Jurisdictional Scope: Valid only within Argentina unless extended or licensed internationally.

This patent likely fits within the broader context of pharmaceutical innovation, potentially covering novel compounds, formulations, manufacturing processes, or therapeutic uses.


Scope and Claims Analysis

1. Nature of Claims

Patent claims define the legal boundaries of invention protection. They are classified into:

  • Independent claims: Broadest, establishing core invention features.
  • Dependent claims: Narrower, adding specific limitations or embodiments.

Given typical pharmaceutical patents, AR121476 probably includes:

  • Chemical composition claims—covering the active compound's structure.
  • Formulation claims—tightly regulating the drug's formulation components.
  • Use claims—specifying therapeutic indications or methods of treatment.
  • Method claims—detailing manufacturing processes.

2. Claim Scope Analysis

  • Broadness: The scope's breadth depends on claim language specificity. If claims cover a broad chemical class or multiple therapeutic indications, protection extends across various embodiments, reducing plain equivalents' risks.

  • Novelty and inventive step: The claims must demonstrate an inventive leap over prior art. For instance, if the claims specify a novel linker or stereochemistry, they likely focus on non-obvious modifications.

  • Functional vs. structural claims: Functional claims (e.g., "a method of treating condition X") could be more susceptible to design-around attempts, whereas structural claims (e.g., specific chemical formulae) tend to offer stronger protection.

3. Key Claim Features

Though exact claims are inaccessible here, standard components are:

  • Chemical structure claims: Defining the molecular scaffold with specific substituents.
  • Pharmacological properties: Demonstrating enhanced efficacy or reduced side effects.
  • Formulation claims: Covering particular excipient combinations enhancing stability or bioavailability.
  • Use claims: Covering methods of treatment for specific medical conditions.

4. Claim Limitations and Vulnerabilities

  • Ambiguous language might weaken enforcement.
  • Narrow claims may invite challenge or design-around strategies.
  • Prior art references, especially recent publications or patents, could limit enforceability.

Patent Landscape and Elevating Patent Strength

1. Prior Art and Overlap

Analyzing the patent landscape contextualizes AR121476's strength:

  • Preexisting patents or publications—including WO, US, EP, or other Latin American patents—may overlap. Example: If similar compounds or methods have been disclosed, claims should explicitly specify novel features.
  • Known compounds or therapeutic methods limit claim scope if not sufficiently distinguished.

2. Patent Families and Related Applications

  • Family members: If AR121476 is part of a patent family, broader geographic protection may be obtainable.

3. Competitor Analysis

  • Existing patents: Identifying competing patents helps assess freedom-to-operate and potential infringement risks.
  • Litigation history: Past patent disputes could influence enforcement risks.

4. Patent Exclusivity and Market Impact

  • Strong claims increase the possibility of exclusive commercialization rights.
  • Narrow claims might necessitate supplementary patenting strategies, such as filing additional applications covering specific formulations or methods.

Legal and Strategic Considerations

  • Validity: Patent validity relies on novelty, inventive step, and industrial applicability.
  • Enforceability: Strong claim language and differentiation from prior art underpin enforcement strategies.
  • Lifecycle management: Strategic maintenance and potential for continuations or divisional filings extend the patent's commercial lifespan.

Conclusion and Strategic Insights

This patent analysis indicates that AR121476's strength hinges on the specificity of its claims. Broad, structurally defined claims associated with a novel chemical entity or therapeutic method can provide robust protection. Conversely, overly narrow claims or references to known compounds may diminish enforceability.

Professionals should:

  • Conduct detailed claim-by-claim analyses against the Argentine patent database for exact claim language.
  • Monitor similar patents domestically and internationally.
  • Consider potential avenues for patent extension or supplementary filings, especially in related jurisdictions.
  • Evaluate patent validity and enforceability periodically, noting any challenges from prior art.

By aligning patent strategy with these insights, pharmaceutical developers and legal teams can effectively leverage AR121476 within Argentina's competitive landscape.


Key Takeaways

  • Claim Breadth is Critical: Broader, structurally specific claims maximize patent scope, while overly narrow claims limit enforceability.
  • Landscape Awareness Enhances Positioning: Understanding potential overlaps facilitates proactive patent drafting and defends market exclusivity.
  • Vigilant Monitoring for Prior Art: Regular patent landscape scans identify emerging threats or opportunities.
  • Leverage Patent Families: Developing international counterparts broadens market exclusivity post-Argentine patent expiry.
  • Legal Precision Underscores Protection: Clear, unambiguous claim language is fundamental for enforcement and licensing success.

Frequently Asked Questions

1. What is the typical duration of patent protection for pharmaceutical patents in Argentina?
In Argentina, pharmaceutical patents generally last 20 years from the earliest filing date, subject to maintaining annual renewal fees.

2. How can differences in claim scope impact patent enforcement?
Broader claims offer wider protection but risk invalidation if too vague or overlapping with prior art. Narrow claims are easier to defend but limit market exclusivity.

3. What are common strategies to strengthen a pharmaceutical patent after grant?
Filing continuation applications, divisional patents, or supplementary protection certificates (SPCs) can extend protection and cover additional embodiments.

4. How does the patent landscape influence potential licensing opportunities?
A well-differentiated patent with broad claims increases licensing attractiveness and negotiating leverage.

5. Can patent AR121476 be enforced against generic competitors?
If the claims are valid and infringed, the patent can be enforced through legal action; however, this depends on claim strength and prior art considerations.


References

  1. Argentine National Institute of Industrial Property (INPI). Official Patent Database.
  2. WIPO Patent Scope Database.
  3. World Patent Index Reports.
  4. Argentine Patent Law and Regulations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.